Neuronetics (STIM) EPS (Basic) (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.00% |
| Dec 31, 2025 | 23.08% |
| Sep 30, 2025 | 13.33% |
| Jun 30, 2025 | 28.57% |
| Mar 31, 2025 | 38.24% |
| Dec 31, 2024 | 22.73% |
| Sep 30, 2024 | -33.33% |
| Jun 30, 2024 | -22.22% |
| Mar 31, 2024 | -50.00% |
| Dec 31, 2023 | 45.45% |
| Sep 30, 2023 | -94.12% |
| Jun 30, 2023 | 55.26% |
| Mar 31, 2023 | -26.67% |
| Dec 31, 2022 | -7.14% |
| Sep 30, 2022 | 28.21% |
| Jun 30, 2022 | 4.88% |
| Mar 31, 2022 | -46.43% |
| Dec 31, 2021 | 9.68% |
| Sep 30, 2021 | -6.90% |
| Jun 30, 2021 | 6.45% |
| Mar 31, 2021 | -63.16% |
| Dec 31, 2020 | -5.56% |
| Sep 30, 2020 | 56.10% |
| Jun 30, 2020 | 39.71% |
| Mar 31, 2020 | -65.85% |
| Dec 31, 2019 | -10.81% |
| Sep 30, 2019 | 5.13% |
| Jun 30, 2019 | 7.14% |
| Mar 31, 2019 | -20.00% |
| Dec 31, 2018 | -20.69% |
| Sep 30, 2018 | 99.05% |
| Jun 30, 2018 | -25.26% |
| Mar 31, 2018 | -4.67% |
| Dec 31, 2017 | -20.62% |
| Sep 30, 2017 | -16.71% |
| Jun 30, 2017 | 38.66% |